ATE308996T1 - Gelträgerstoffe für antiproliferierende mittel - Google Patents
Gelträgerstoffe für antiproliferierende mittelInfo
- Publication number
- ATE308996T1 ATE308996T1 AT98908583T AT98908583T ATE308996T1 AT E308996 T1 ATE308996 T1 AT E308996T1 AT 98908583 T AT98908583 T AT 98908583T AT 98908583 T AT98908583 T AT 98908583T AT E308996 T1 ATE308996 T1 AT E308996T1
- Authority
- AT
- Austria
- Prior art keywords
- agents
- antiproliferant
- gel carrier
- antiproliferative
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/803,128 US6630168B1 (en) | 1997-02-20 | 1997-02-20 | Gel delivery vehicles for anticellular proliferative agents |
PCT/US1998/003107 WO1998036776A2 (en) | 1997-02-20 | 1998-02-19 | Gel delivery vehicles for anticellular proliferative agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE308996T1 true ATE308996T1 (de) | 2005-11-15 |
Family
ID=25185657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98908583T ATE308996T1 (de) | 1997-02-20 | 1998-02-19 | Gelträgerstoffe für antiproliferierende mittel |
Country Status (13)
Country | Link |
---|---|
US (4) | US6630168B1 (de) |
EP (1) | EP0971745B1 (de) |
JP (1) | JP2001512487A (de) |
KR (1) | KR100611137B1 (de) |
CN (1) | CN1212154C (de) |
AT (1) | ATE308996T1 (de) |
AU (1) | AU746938B2 (de) |
CA (1) | CA2281919A1 (de) |
DE (1) | DE69832266T2 (de) |
HK (1) | HK1026142A1 (de) |
NO (1) | NO994015L (de) |
NZ (1) | NZ337875A (de) |
WO (1) | WO1998036776A2 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6630168B1 (en) * | 1997-02-20 | 2003-10-07 | Biomedicines, Inc. | Gel delivery vehicles for anticellular proliferative agents |
US6040330A (en) * | 1999-01-08 | 2000-03-21 | Bionumerik Pharmaceuticals, Inc. | Pharmaceutical formulations of taxanes |
EP1387676A2 (de) * | 2001-05-01 | 2004-02-11 | Angiotech Pharmaceuticals, Inc. | Zusammensetzung enthaltend eine substanz mit anti-mikrotubulärer wirkung und ein polysaccharid oder polypeptid und ihre verwendung zur herstellung eines medikaments zur behandlung von entzündlichen erkrankungen |
CA2456746A1 (en) * | 2001-08-20 | 2003-02-27 | Transave, Inc. | Method for treating lung cancers |
WO2003034988A2 (en) * | 2001-10-19 | 2003-05-01 | Idexx Laboratories, Inc. | Injectable compositions for the controlled delivery of pharmacologically active compound |
US6946137B2 (en) * | 2001-10-19 | 2005-09-20 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
AU2003302314A1 (en) * | 2002-08-02 | 2004-07-09 | Transave, Inc. | Platinum aggregates and process for producing the same |
US9186322B2 (en) * | 2002-08-02 | 2015-11-17 | Insmed Incorporated | Platinum aggregates and process for producing the same |
US7670627B2 (en) * | 2002-12-09 | 2010-03-02 | Salvona Ip Llc | pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients |
CN100548228C (zh) * | 2003-11-13 | 2009-10-14 | 阿尔扎公司 | 用于透皮递送的组合物和装置 |
US20040224019A1 (en) * | 2004-03-03 | 2004-11-11 | Adi Shefer | Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs |
CN1976711A (zh) * | 2004-03-18 | 2007-06-06 | 特兰萨维股份有限公司 | 通过吸入给药顺铂 |
US20070065522A1 (en) * | 2004-03-18 | 2007-03-22 | Transave, Inc. | Administration of high potency platinum compound formulations by inhalation |
CA2566174A1 (en) * | 2004-05-21 | 2005-12-01 | Transave, Inc. | Treatment of lung diseases and pre-lung disease conditions |
US7858115B2 (en) | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
JP5324091B2 (ja) * | 2004-06-24 | 2013-10-23 | アイデックス ラボラトリーズ,インコーポレイティド | 薬物送達のための医薬組成物及びそれを使用する症状の治療又は予防法 |
US7854943B2 (en) | 2004-06-24 | 2010-12-21 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
US7618651B2 (en) | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
MX2007004955A (es) * | 2004-11-08 | 2007-06-14 | Transave Inc | Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente. |
US20060141040A1 (en) * | 2004-12-23 | 2006-06-29 | Guohua Chen | Injectable non-aqueous suspension |
WO2007056264A2 (en) * | 2005-11-08 | 2007-05-18 | Transave, Inc. | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
US20070190180A1 (en) * | 2005-11-08 | 2007-08-16 | Pilkiewicz Frank G | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously |
US9107824B2 (en) | 2005-11-08 | 2015-08-18 | Insmed Incorporated | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
WO2007056236A2 (en) * | 2005-11-08 | 2007-05-18 | Transave, Inc. | Methods of treating cancer with lipid-based platinum compound formulations administered intravenously |
WO2007064658A2 (en) * | 2005-11-30 | 2007-06-07 | Transave, Inc. | Safe and effective methods of administering therapeutic agents |
US20070248630A1 (en) * | 2006-04-20 | 2007-10-25 | Friden Phillip M | Pharmaceutical formulations for iontophoretic methotrexate delivery |
JP2015530387A (ja) | 2012-09-04 | 2015-10-15 | エライゾン ファーマシューティカルズ, エルエルシー | 脂質複合体化シスプラチンによる肺癌の再発防止 |
CA2931547A1 (en) | 2013-12-09 | 2015-06-18 | Durect Corporation | Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same |
US20160346221A1 (en) | 2015-06-01 | 2016-12-01 | Autotelic Llc | Phospholipid-coated therapeutic agent nanoparticles and related methods |
MY194732A (en) * | 2015-09-18 | 2022-12-15 | Huntsman Petrochemical Llc | Improved poly(vinyl caprolactam) kinetic gas hydrate inhibitor and method for preparing the same |
WO2020081148A1 (en) * | 2018-10-16 | 2020-04-23 | US Nano Food & Drug INC | Intratumor injection formulation |
IN202121042020A (de) * | 2021-09-17 | 2023-03-24 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3888995A (en) * | 1968-07-19 | 1975-06-10 | Syntex Corp | Fatty alcohol-propylene glycol vehicle |
CA1248450A (en) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Soft patch |
US4619913A (en) | 1984-05-29 | 1986-10-28 | Matrix Pharmaceuticals, Inc. | Treatments employing drug-containing matrices for introduction into cellular lesion areas |
JPS6219528A (ja) | 1985-07-16 | 1987-01-28 | Kurorera Kogyo Kk | 制癌剤 |
DE3603444A1 (de) * | 1986-02-05 | 1987-08-06 | Thomae Gmbh Dr K | Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha |
JPH0730029B2 (ja) * | 1986-09-08 | 1995-04-05 | 株式会社クラレ | 1−置換アザシクロヘプタン−2−オン及びこれを含有する経皮投与用薬剤 |
DE3631413A1 (de) | 1986-09-16 | 1988-03-24 | Knoll Ag | Therapeutisches system zur lokalen applikation von pharmawirkstoffen |
US5719197A (en) | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US5051257A (en) | 1989-05-09 | 1991-09-24 | Pietronigro Dennis D | Antineoplastic solution and method for treating neoplasms |
US5487897A (en) * | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
SE8904296D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Transdermal system |
CA2061566C (en) | 1992-02-20 | 2002-07-09 | Rudolf E. Falk | Treatment of disease employing hyaluronic acid and nsaids |
GB9310049D0 (en) | 1993-05-12 | 1993-06-30 | Cancer Res Campaign Tech | Growth factor effects |
CA2180260A1 (en) * | 1993-12-29 | 1995-07-06 | Dennis M. Brown | Methods and compositions for the treatment of a host with a cellular proliferative disease |
DK0754032T3 (da) * | 1994-04-08 | 2002-04-02 | Atrix Lab Inc | Flydende frigivelsessammensætninger |
US5603955A (en) * | 1994-07-18 | 1997-02-18 | University Of Cincinnati | Enhanced loading of solutes into polymer gels |
US5567420A (en) * | 1994-11-16 | 1996-10-22 | Mceleney; John | Lotion which is temporarily colored upon application |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
EP1039885A1 (de) | 1996-12-17 | 2000-10-04 | Lidak Pharmaceuticals | Verwendung von c18 bis c26-aliphatischen alkoholen zur herstellung eines medikaments für die behandlung von hyperproliferativen hauterkrankungen |
US5993856A (en) | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
US6630168B1 (en) * | 1997-02-20 | 2003-10-07 | Biomedicines, Inc. | Gel delivery vehicles for anticellular proliferative agents |
-
1997
- 1997-02-20 US US08/803,128 patent/US6630168B1/en not_active Expired - Fee Related
-
1998
- 1998-02-19 AU AU66583/98A patent/AU746938B2/en not_active Ceased
- 1998-02-19 CN CNB988036606A patent/CN1212154C/zh not_active Expired - Fee Related
- 1998-02-19 AT AT98908583T patent/ATE308996T1/de not_active IP Right Cessation
- 1998-02-19 WO PCT/US1998/003107 patent/WO1998036776A2/en not_active Application Discontinuation
- 1998-02-19 CA CA002281919A patent/CA2281919A1/en not_active Abandoned
- 1998-02-19 DE DE69832266T patent/DE69832266T2/de not_active Expired - Fee Related
- 1998-02-19 KR KR1019997007602A patent/KR100611137B1/ko not_active IP Right Cessation
- 1998-02-19 EP EP98908583A patent/EP0971745B1/de not_active Expired - Lifetime
- 1998-02-19 JP JP53681598A patent/JP2001512487A/ja not_active Ceased
- 1998-02-19 NZ NZ337875A patent/NZ337875A/en unknown
-
1999
- 1999-08-19 NO NO994015A patent/NO994015L/no unknown
-
2000
- 2000-02-16 US US09/505,303 patent/US6669958B1/en not_active Expired - Fee Related
- 2000-08-30 HK HK00105425A patent/HK1026142A1/xx not_active IP Right Cessation
-
2003
- 2003-09-03 US US10/654,690 patent/US20040076679A1/en not_active Abandoned
- 2003-12-18 US US10/741,284 patent/US20040131646A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR100611137B1 (ko) | 2006-08-10 |
NZ337875A (en) | 2001-09-28 |
AU6658398A (en) | 1998-09-09 |
CN1212154C (zh) | 2005-07-27 |
WO1998036776A2 (en) | 1998-08-27 |
WO1998036776A3 (en) | 1998-11-26 |
DE69832266T2 (de) | 2006-08-03 |
EP0971745A2 (de) | 2000-01-19 |
DE69832266D1 (de) | 2005-12-15 |
AU746938B2 (en) | 2002-05-09 |
KR20000075543A (ko) | 2000-12-15 |
CN1251045A (zh) | 2000-04-19 |
EP0971745B1 (de) | 2005-11-09 |
NO994015D0 (no) | 1999-08-19 |
US6630168B1 (en) | 2003-10-07 |
CA2281919A1 (en) | 1998-08-27 |
US20040131646A1 (en) | 2004-07-08 |
US20040076679A1 (en) | 2004-04-22 |
HK1026142A1 (en) | 2000-12-08 |
NO994015L (no) | 1999-10-15 |
US6669958B1 (en) | 2003-12-30 |
JP2001512487A (ja) | 2001-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE308996T1 (de) | Gelträgerstoffe für antiproliferierende mittel | |
DE69840660D1 (de) | Mobiles Kommunikationssystem und mobiles Kommunikationsverfahren dafür | |
BRPI0417254A (pt) | métodos e equipamentos para roaming cdma2000/gprs | |
ATE202132T1 (de) | Vernetzte biokompatible verkapselungszusammensetzungen und verfahren | |
IT1296459B1 (it) | Attrezzatura interna per veicolo, quale, ad esempio, autoveicolo. | |
ATE362270T1 (de) | Verfahren und mechanismus zum übertragen von nachrichten | |
IL132115A0 (en) | Drug preparations for treating sexual dysfunction | |
DE69938073D1 (de) | Kraftfahrzeug-Kommunikationsverfahren, und System dafür | |
DE60035907D1 (de) | Mobiles Kommunkationsgerät, Kommunikationssystem und Kommunikationsverfahren | |
FI956185A (fi) | Matkaviestinlaite, erityisesti junaviestintään | |
DE69717999D1 (de) | Bis-platin komplexe mit polyamin-liganden als antitumorales mittel | |
IT1282731B1 (it) | Morsetto di batteria per autoveicolo. | |
EE200000367A (et) | Mobiilraadioside meetod, seade ja terminal | |
FI964416A0 (fi) | Tiedonsiirtomenetelmä, solukkojärjestelmä ja matkaTiedonsiirtomenetelmä, solukkojärjestelmä ja matkaviestin viestin | |
IT8919717A0 (it) | Equipaggiamento elettrico di trazione, in particolare per veicoli da trasporto pubblico. | |
DE69827832D1 (de) | Mobile kommunikationsanordnung und mobiles kommunikationsverfahren | |
ITRM980002A0 (it) | Metodo ed apparato per l'immagazzinamento di apparecchiature, macchinari e mezzi mobili, in atmosfera controllata. | |
DE60025518D1 (de) | Hypoglykämische mittel, die organische zinkkomplexe enthalten | |
DE50016077D1 (de) | Antriebssystem für Fahrzeuge, insbesondere für Nutzkraftwagen und elektrische Baueinheit | |
WO2000058506A3 (en) | Susceptibility to psoriasis | |
ES1036631Y (es) | Dispositivo perfeccionado, adaptable y portador para telefonos moviles. | |
MX9702042A (es) | Piridinas sustituidas por 2-arilo. | |
WO1999024052A3 (en) | Use of protein h as cytostatic agent | |
BR9701024B1 (pt) | processo e aparelho para localização de telefone e estação móvel. | |
IT1285063B1 (it) | Dispositivo antinebulizzazione per veicoli, in particolare veicoli industriali. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |